Retraction

MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

Citations (32)

32
Total Citations
4
Post-Retraction
(12.5%)
28
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
4 Within 1 year
0 After 2+ years
262 Days since retraction (latest)
Embryonic heat conditioning induces paternal heredity of immunological cross- tolerance: coordinative role of CpG DNA methylation and miR-200a regulation
Padma Malini Ravi, Tatiana Kisliouk, S. Druyan et al. (7 authors)
Frontiers in Immunology Open Access
Published: Feb 2025
262 days after retraction
Paper citing MicroRNA-200a inhibits inflammation and atheroscle...
Unknown Authors
Unknown Journal
Published: Jan 2025
225 days after retraction
Sodium Danshensu Inhibits Macrophage Inflammation in Atherosclerosis via the miR-200a-3p/MEKK3/NF-κB Signaling Pathway
Xiaolu Zhang, Yilin Zhang, Miao Zeng et al. (7 authors)
Molecular Neurobiology
Published: Nov 2024
1 citation
178 days after retraction
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis
Misbah Aziz, Karin Jandeleit‐Dahm, Abdul Waheed Khan
Atherosclerosis Open Access
Published: Jun 2024
4 citations
16 days after retraction
Shear-Sensitive circRNA-LONP2 Promotes Endothelial Inflammation and Atherosclerosis by Targeting NRF2/HO1 Signaling
Ruoyu Wang, Yué Zeng, Ziqi Chen et al. (7 authors)
JACC Basic to Translational Science Open Access
Published: May 2024
4 citations
20 days before retraction
Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis
Weijie Liang, Ruibin Wei, Xingxing Zhu et al. (8 authors)
Molecular Medicine Open Access
Published: Mar 2024
6 citations
66 days before retraction
Role of transcriptional cofactors in cardiovascular diseases
Shuqing Mao, Chao Song, Hong Huang et al. (8 authors)
Biochemical and Biophysical Research Communications
Published: Mar 2024
5 citations
71 days before retraction
Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
Yu Zhang, Yanchun Zhang
Open Life Sciences Open Access
Published: Jan 2024
1 citation
141 days before retraction
Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
Bo Zhu, Hao Wu, Kathryn Li et al. (8 authors)
Vascular Pharmacology
Published: Dec 2023
6 citations
166 days before retraction
EZH2 Promotes Corneal Endothelial Cell Apoptosis by Mediating H3K27me3 and Inhibiting HO-1 Transcription
Ying Lin, Huanjun Su, Baoyi Zou et al. (4 authors)
Current Eye Research
Published: Oct 2023
1 citation
228 days before retraction
Epigenetic Network in Immunometabolic Disease
Martin Andreas Geiger, Era Gorica, S A Mohammed et al. (9 authors)
Advanced Biology Open Access
Published: Oct 2023
6 citations
230 days before retraction
EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction
Sun Li, Xuefang Li, Hui Luo et al. (8 authors)
Biochemical Pharmacology Open Access
Published: May 2023
6 citations
369 days before retraction
Role and therapeutic potential of gelsolin in atherosclerosis
Qiang Zhang, Xiaohui Wen, Shilin Tang et al. (5 authors)
Journal of Molecular and Cellular Cardiology
Published: Mar 2023
13 citations
424 days before retraction
Human umbilical cord mesenchymal stem cell-derived exosomes carrying miR-1827 downregulate SUCNR1 to inhibit macrophage M2 polarization and prevent colorectal liver metastasis
Jierong Chen, Ziyue Li, Caifeng Yue et al. (11 authors)
APOPTOSIS
Published: Jan 2023
34 citations
489 days before retraction
MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus—From Pathogenesis to Potential Clinical Application
Joanna Szydełko, Beata Matyjaszek‐Matuszek
International Journal of Molecular Sciences Open Access
Published: Dec 2022
16 citations
509 days before retraction
HMGB1 promotes Ox-LDL-induced endothelial cell damage by inhibiting PI3K/Akt signaling pathway
Xin Huo, Boyou Su, Guoti Qin et al. (4 authors)
BMC Cardiovascular Disorders Open Access
Published: Dec 2022
10 citations
517 days before retraction
Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression
Kaiji Xie, Jingxin Zeng, Liming Wen et al. (11 authors)
Atherosclerosis
Published: Nov 2022
3 citations
545 days before retraction
Genome-wide post-transcriptional regulation of bovine mammary gland response to Streptococcus uberis
Raana Tabashiri, Somayeh Sharifi, A. Pakdel et al. (7 authors)
Journal of Applied Genetics
Published: Sep 2022
5 citations
623 days before retraction
Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate wide-spread non-receptor mediated immune cell recruitment
Anna L. Gray, Richard Karlsson, Abigail R. E. Roberts et al. (18 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Jul 2022
1 citation
681 days before retraction
A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions
H Yoshimatsu, Kosuke Kataoka, Kohtaro Fujihashi et al. (5 authors)
Vaccine Open Access
Published: Jan 2022
5 citations
848 days before retraction
Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment
Steven R. Botts, Jason E. Fish, Kathryn L. Howe
Frontiers in Pharmacology Open Access
Published: Dec 2021
119 citations
881 days before retraction
Lnc-C2orf63-4-1 Confers VSMC Homeostasis and Prevents Aortic Dissection Formation via STAT3 Interaction
Song Zhang, Shiqi Zhao, Xuejie Han et al. (16 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: Dec 2021
15 citations
897 days before retraction
Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis
Anvarsadat Kianmehr, Durdi Qujeq, Abouzar Bagheri et al. (4 authors)
Critical Reviews in Clinical Laboratory Sciences
Published: Sep 2021
14 citations
979 days before retraction
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases
Yang Yang, Ying Luan, Ruixia Yuan et al. (4 authors)
Frontiers in Cardiovascular Medicine Open Access
Published: Sep 2021
20 citations
985 days before retraction
microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis
Jianyuan Pan, Buse Alexan, Dorn Dennis et al. (6 authors)
Journal of Translational Medicine Open Access
Published: Sep 2021
23 citations
985 days before retraction
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou et al. (7 authors)
Biomedicines Open Access
Published: Jul 2021
377 citations
1050 days before retraction
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little et al. (15 authors)
Pharmacological Reviews Open Access
Published: Jun 2021
746 citations
1082 days before retraction
EZH2 as an Epigenetic Regulator of Cardiovascular Development and Diseases
Jiali Yuan, Chengye Yin, Ying-Ze Li et al. (6 authors)
Journal of Cardiovascular Pharmacology
Published: May 2021
24 citations
1093 days before retraction
Electroacupuncture promotes the recovery of rats with spinal cord injury by suppressing the Notch signaling pathway via the H19/ EZH2 axis
Peng Geng, Yanghong Zou, Shipeng Li et al. (8 authors)
Annals of Translational Medicine Open Access
Published: May 2021
10 citations
1116 days before retraction
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy
Laura Iop
Frontiers in Cardiovascular Medicine Open Access
Published: Mar 2021
5 citations
1174 days before retraction
The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1
Jolien Fledderus, Byambasuren Vanchin, Marianne G. Rots et al. (4 authors)
Journal of Personalized Medicine Open Access
Published: Feb 2021
22 citations
1201 days before retraction
<scp>Enhancer of zeste homolog 2</scp>participates in the process of atherosclerosis by modulating<scp>microRNA</scp>‐139‐5p methylation and signal transducer and activator of transcription 1 expression
Xuwei Zheng, Xiaoyan Zhao, Zhanying Han et al. (4 authors)
IUBMB Life Open Access
Published: Dec 2020
15 citations
1251 days before retraction
Quick Stats
Total Citations: 32
Years Since Retraction: 1.5 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers